News

Apexian Pharmaceuticals’ Dr. Mark Kelley recognized as an outstanding researcher at Indiana University/Purdue University IUPUI

Indianapolis, IN - Apexian Pharmaceuticals, a clinical-stage biotechnology company focused on developing safe and effective therapy for patients with high unmet medical needs, is pleased to announce that its Chief Scientific Officer, Mark Kelley, PhD, was recognized as an outstanding scholar and researcher during the annual IUPUI Chancellor's Academic Honors Convocation on April 20. Dr. Kelley was named the recipient of the Glenn W. Irwin Jr.,...

Apexian Pharmaceuticals to present two poster sessions at AACR meeting in Chicago – April 14-18, 2018

Indianapolis, IN – April 14, 2018 –Apexian Pharmaceuticals, a clinical-stage biotechnology company focused on developing safe and effective therapy for patients with high unmet medical needs, is pleased to announce that it will present two key poster sessions at the upcoming American Association for Cancer Research (AACR) Meeting, which will be held at McCormick Place in Chicago, Illinois from April 14 – 18, 2018.  Dr....